🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 2

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 2 of 9
JessicaH_TX
Senior Member
4,123
13,456
Dec 2023
Houston, TX
Jul 12, 2025 at 9:37 AM#6
Dr.NateNeph said:
Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then…

I read this differently from Dr.NateNeph, on substance rather than tone. Small molecule does not automatically mean cheap. Price is set by what the market will bear and by patent life, not by cost of goods, and I would not assume the savings reach patients.

23 18wendy_avl, jason_paloalto, Dr.LeslieOBGYN and 20 others
Reply Quote Save Share Report
FDA_TrackerJim
Senior Member
1,567
7,890
Feb 2024
Rockville, MD
Jul 12, 2025 at 10:43 AM#7

Adding the numbers, since they settle part of this. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

That is the short version; the long version is somebody else's post.

22 17Admin, Dr.Martinez, mike_mod and 19 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Jul 12, 2025 at 11:49 AM#8
JessicaH_TX said:
Small molecule does not automatically mean cheap.

There is a second half to this that has not been said yet. It helps to say which part of this you are uncertain about. A precise question gets a precise answer; a general one gets everybody’s favourite anecdote.

21 16Admin, Dr.Martinez, mike_mod and 18 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Jul 12, 2025 at 12:55 PM#9

A narrower follow-up, since the general answer is now clear:

How long did you give it before you decided it was working?

Last edited: Jul 12, 2025 at 1:55 PM
20 15NicoleRaleigh, james_edin, FranDenver and 17 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Jul 12, 2025 at 6:12 PM#10

Reporting back.

Update, and it is the boring outcome: nothing was wrong. The measurement I was reading had moved less than its own week-to-week variation, which somebody said upthread and I did not believe.

Last edited: Jul 13, 2025 at 12:12 AM
8 6kim_atl_prep, sarah_TO, wendy_avl and 5 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register